Real-time Euronext Paris 03:25:37 2024-04-18 am EDT 5-day change 1st Jan Change
0.072 EUR +2.86% Intraday chart for Implanet SA -3.49% +12.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Implanet: first-quarter sales up slightly CF
Implanet S.A. Reports Revenue Results for the First Quarter of 2024 CI
Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Implanet S.A. Announces Board Changes CI
Implanet Completes EUR5.5 Million Capital Raise MT
Implanet S.A. announced that it has received ?5 million in funding from Shanghai Sanyou Medical Co., Ltd CI
Implanet S.A. Reports Revenue Results for the Fourth Quarter and Full Year 2023 CI
Sanyou Medical Eyes Controlling Stake in French Peer Implanet For Up to 5 Million Euros MT
Implanet S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Implanet Shares Soar Amid EUR5 Million Funding Deal with Sanyou Medical MT
Implanet S.A. announced that it expects to receive ?5 million in funding from Shanghai Sanyou Medical Co., Ltd CI
Implanet Launches New Minimally Invasive Screw System for Spine Surgeries in Europe MT
IMPLANET Announces the European Launch of the MIS Range, a Minimally Invasive Pedicle Screw System CI
Implanet S.A. Appoints David FAN to the Board of Directors CI
Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
France's Implanet Wins US FDA Nod for Anterior Cervical Cage MT
Implanet S.A. Signs an Exclusive Distribution Contract for SMTP Technology Co.’s Ultrasonic Surgical Scalpel in France CI
IMPLANET Signs a Distribution Agreement With Shanghai Sanyou Medical Co, Ltd. in China and a Technological Partnership for the Development of a New Product Range CI
Implanet Raises $3 Million Via Shares, Warrants Issue; Sanyou Medical Boosts Stake to 29% MT
Implanet S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Implanet S.A. Reports Revenue for the Second Quarter and First Half of 2022 CI
Implanet Announces A Commercial, Technological and Financial Partnership with Sanyou Medical CI
Implanet S.A. Announces Consolidated Revenue Results for the First Quarter of 2022 CI
Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
IMPLANET Announces the First Surgical Procedures in the United States with JAZZ PF CI
Chart Implanet SA
More charts
Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - spine surgery (94.9%); - knee surgery and arthroscopy (1%). The balance of net sales (4.1%) concerns the medical equipment distribution activity. Net sales are distributed geographically as follows: France (47.1%), Europe/Middle East/Africa (14.3%), the United States (18.5%) and other (20.1%).
Calendar
More about the company

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALIMP Stock
  4. News Implanet SA
  5. Implanet : Nears Deal To Sell Knee Prosthesis To Focus On Spine Business